Lotus Pharmaceutical Co (美時化學製藥) on Monday reported record earnings per share of NT$4.22 for last year, up from NT$2.74 in 2019, thanks to increased revenue and improved operating profit.
The company, one of the nation’s leading specialty generic drug developers, said that revenue hit a record NT$10.72 billion (US$375.9 million) last year on the back of robust exports.
Sales generated by its Asian operations grew 10.8 percent year-on-year, supported by accelerated growth in Thailand and Vietnam, as well as steady expansion in Taiwan and South Korea, the company said in a statement.
The company’s gSuboxone, a generic version of Indivior Inc’s Suboxone, which is used in the treatment of opioid use disorder, had as of the end of last year seized a 38 percent market share in the US — making it the market leader and boosting its export business, it said.
Lotus said that improved operating profit came as research and development expenses last year declined 8.7 percent, while marketing expenses fell 3.9 percent.
“Most major objectives set throughout the year were delivered as scheduled and we are confident of kicking off substantial growth in 2021,” Lotus Pharmaceutical chief executive officer Petar Vazharov said in the statement.
Last year, a new warehouse was built and the company’s oncology production line was upgraded, which would increase efficiency, Vazharov said.
The company has not finalized the distribution of a cash dividend this year, but it did not distribute cash dividends for the past nine years due to accumulated losses, which totaled NT$995 million at the end of 2019.
Three experts in the high technology industry have said that US President Donald Trump’s pledge to impose higher tariffs on Taiwanese semiconductors is part of an effort to force Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) to the negotiating table. In a speech to Republicans on Jan. 27, Trump said he intends to impose tariffs on Taiwan to bring chip production to the US. “The incentive is going to be they’re not going to want to pay a 25, 50 or even a 100 percent tax,” he said. Darson Chiu (邱達生), an economics professor at Taichung-based Tunghai University and director-general of
‘LEGACY CHIPS’: Chinese companies have dramatically increased mature chip production capacity, but the West’s drive for secure supply chains offers a lifeline for Taiwan When Powerchip Technology Corp (力晶科技) entered a deal with the eastern Chinese city of Hefei in 2015 to set up a new chip foundry, it hoped the move would help provide better access to the promising Chinese market. However, nine years later, that Chinese foundry, Nexchip Semiconductor Corp (合晶集成), has become one of its biggest rivals in the legacy chip space, leveraging steep discounts after Beijing’s localization call forced Powerchip to give up the once-lucrative business making integrated circuits for Chinese flat panels. Nexchip is among Chinese foundries quickly winning market share in the crucial US$56.3 billion industry of so-called legacy
Hon Hai Precision Industry Co (鴻海精密) is reportedly making another pass at Nissan Motor Co, as the Japanese automaker's tie-up with Honda Motor Co falls apart. Nissan shares rose as much as 6 percent after Taiwan’s Central News Agency reported that Hon Hai chairman Young Liu (劉揚偉) instructed former Nissan executive Jun Seki to connect with French carmaker Renault SA, which holds about 36 percent of Nissan’s stock. Hon Hai, the Taiwanese iPhone-maker also known as Foxconn Technology Group (富士康科技集團), was exploring an investment or buyout of Nissan last year, but backed off in December after the Japanese carmaker penned a deal
WASHINGTON POLICY: Tariffs of 10 percent or more and other new costs are tipped to hit shipments of small parcels, cutting export growth by 1.3 percentage points The decision by US President Donald Trump to ban Chinese companies from using a US tariff loophole would hit tens of billions of dollars of trade and reduce China’s economic growth this year, according to new estimates by economists at Nomura Holdings Inc. According to Nomura’s estimates, last year companies such as Shein (希音) and PDD Holdings Inc’s (拼多多控股) Temu shipped US$46 billion of small parcels to the US to take advantage of the rule that allows items with a declared value under US$800 to enter the US tariff-free. Tariffs of 10 percent or more and other new costs would slash such